Zentalis Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (ZNTL)

Q3 2023 13F Holders as of 9/30/2023

Type / Class: Equity / Common Stock, $0.001 par value per share
Number of holders: 134
Total Shares: 80M
Shares change: -2.24M
Total reported value, excl. options: $1.61B
Value change: -$51.6M
Put/Call ratio: 0.2
Number of buys: 66
Number of sells: -50
Price: $20.06

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.